Cost control tops global benefits priorities in 2026, but most Canadian employers are refusing to cut coverage or shift costs to workers
Medavie Blue Cross’ Marie-Hélène Dugal explains how generic semaglutide is reigniting mandatory generic substitution in plans
Nigel Branker explains why 'better outcomes start with better access' for women
Consultants share how fiduciary duty plays a critical role in managing plan sponsors’ challenges and benefits plans
Equitable’s Meghan Vallis outlines the blind spots that plan sponsors need to address in benefits
